Forskning ved Københavns Universitet - Københavns Universitet

Forside
Flemming Fryd Johansen
Flemming Fryd Johansen

Professor MSO

 

Curriculum Vitae 

Flemming Fryd Johansen, professor,

Fødselsdato: 29-11-1952

E-mail: flemming.johansen@bric.dk

Telefon: 28756040

 

Akademiske grader

1993              dr.med, Københavns Universitet (KU)

1983              cand.med, KU

 

Udnævnelser

2010              Professor i eksperimentel patologi; Biomedicinsk Institut (BMI), KU

2006              Professor i eksperimentel neuropatologi; BMI, KU

2006 -            Sektionsleder, Institut for Molekylær Patologi; BMI, KU

2004 - 2006   Institutleder, Institut for Molekylær Patologi; KU

2001 -            Leder & koordinator på de patologiske kurser for medicinstuderende, odontologistuderende, molekylær biomedicin studerende og humanbiolog studerende på KU.

1997              Lektor, Institut for Molekylær Patologi; KU

1984 - 1997   Adjunkt samt andre udnævnelser ved Institut for Neuropatologi; KU

1983 - 1984   Turnus; Geriatrisk Afdeling og Plastikkirurgisk Afdeling, Rigshospitalet

 

Forskeruddannelse         

1994 - 1995   131 hjernebiopsier, Retsmedicinsk Institut, KU

1993 - 1994   Postdoc: molecular neurobiology, single cell RT-PCR, and adenovirus as vector (Pr. J Rossier) Institut Alfred Fessard, CNRS Gif-sur-Yvette, Paris

1985 + 1987  Forskningsassistent: immunocytochemistry og in situ hybridization (Pr. J-Y Wu),The Milton S. Hershey Medical Centre, Hershey, USA

 

Akademiske arbejdsopgaver

  • Medlem af The Faculty Strategic Research Committee, SUND, KU (2006-2012)
  • Brugerudvalgsformand for den virtuelle mikroskopi, KU
  • Grundlagde i 2002 det årlige møde for danske hjerneforskningslaboratorier =

          Odense-Aarhus-København (OAK meetings) ~ www.oak.sdu.dk

  • Co-Editor på Neurochemical Research (2003-2012)
  • Referee ved en række internationale tidsskrifter samt The Welcome Trust & MRC (UK)

 

Publikationer, konferencer og vejledning

88 artikler (Peer-reviewed: 65; Congress Volumes: 20; Monographs: 3). Mere end 40 mundtlige præsentationer ved international konferencer. Ordstyrer ved 10 nationale og 3 internationale konferencer. Vejleder for 10 PhD- (2000-2012) og 43 bachelor studerende (1999-2013). Pr 1/1-2013 vejleder for 2 PhD studerende. Opponent ved 2 DMSc (dr.med. : 2002-2004), 20 PhD- (1996-2013) and 37 bachelor projekter (1992-2013)

 

Forskningsekspertise

Eksperimentel neuropatologi –  cerebral iskæmi & multipel sclerose (dyremodeller i sygdomsforskning)

 

Forskningsmidler

2002-2005     Indtil 2005 ~  3.318.760 kr.

2005-2010     Sammen med Jacob Hansen-Schwartz, totalt ~  1.175.175 kr.

2012              11 Bevillinger, totalt: ~  640.075 kr. til cerebral iskæmi forskning

 

Seneste publikationer

88.Johansen FF, Hasseldam H, Rasmussen RS, Bisgaard AS, Bonfils PK, Poulsen SS, Hansen-Schwartz J. Drug-induced hypothermia as beneficial treatment before and after cerebral ischemia. Pathobiology 2013, in press # 201212006

87. Jacobsen KR, Fauerby N, Raida Z, Kalliokoski O, Hau J, Johansen FF, Abelson KSP. The effects of buprenorphine and meloxicam analgesia on middle cerebral artery occlusion-induced ischemia in C57BL/6 male mice. Comparative Medicine 2013 63(2):105-13.*

86. Hasseldam H, Hansen-Schwartz J, Munkholm N, Hou J, Johansen FF. Remote post-conditioning reduces hypoxic damage early after experimental stroke. Neurol Res 2013 35(4):336-43. *

85. Hasseldam H, Hansen CS, Johansen FF. Immunomodulatory effects of helminths and protozoa in multiple sclerosis and experimental autoimmune encephalomyelitis. Parasite Immunol 2013 35(3-4):103-8. *

84. Eriksen N, Rasmussen RS, Overgaard K, Johansen FF. Pakkenberg B. Comparison of quantitative estimation of intracerebral hemorrhage and infarct volumes after thromboembolism in an embolic stroke model. Int J Stroke 2012 Aug 29. *

83. Povlsen GK, Waldsee R, Ahnstedt H, Kristiansen KA, Johansen FF, Edvinsson L. In vivo experimental stroke and in vitro organ culture induce similar changes in vasoconstrictor receptors and intracellular calcium handling in rat cerebral arteries. Exp Brain Res 2012 219(4):507-20. *

82. Hasseldam H, Johansen FF. Cannabinoid treatment renders neurons less vulnerable than oligodendrocytes in experimental autoimmune encephalomyelitis.International Journal of Neuroscience 2011 121(9):510-20. *

81. Rasmussen RS, Overgaard K, Kristiansen U, Johansen FF. Acute but not delayed amphetamine treatment improves behavioral outcome in a rat embolic stroke model. Neurol Res 2011 33(7):774-82. *

80. Faarup P, Holstein-Rathlou N-H, Nørgaard T, Harrison AP, Bastholm L, Thatt L, Johansen FF, Hegedüs V. Functionally induced changes in water transport in the proximal tubule segment of rat kidney. Int J Nephrol Renovascul Disease 2011 4:73-84.

79. Lambertsen KL, Deierborg T, Gregersen R, Clausen BH, Wirenfeldt M, Nielsen HH, Dalmau I, Diemer NH, Dagnaes-Hansen F, Johansen FF, Keating A, Finsen B. Differences in origin of reactive microglia in bone marrow chimeric mouse and rat after transient global ischemia. J Neuropathol Exp Neurol  2011 70(6):481-494. *

78.  Kalliokoski O, Abelson KSP, Koch J, Boschian A, Thormose SF, Fauerby N, Rasmussen RS, Johansen FF,  Hau J. The effect of voluntarily ingested buprenorphine on rats subjected to surgically induced global cerebral ischaemia. In Vivo 2010 24(5):641-6.

77. Overgaard K, Rasmussen RS, Johansen FF. The site of embolization related to infarct size, oedema and clinical outcome in a rat stroke model - further translational stroke research.Exp Transl Stroke Med 2010 17(2):17-26. *

76. Hasseldam H, Johansen FF. Neuroprotection without immunomodulation is insufficient to reduce first relapse severity in experimental autoimmune encephalomyelitis.Neuroimmunomodulation 2010 17(4):252-64. *

 

Uddannelse

Cand.med, dr.med

ID: 9113